688331 荣昌生物
已收盘 05-28 15:00:01
资讯
新帖
简况
东方证券减持荣昌生物(09995)16万股 每股均价约84.83港元
智通财经 · 05-26 19:30
东方证券减持荣昌生物(09995)16万股 每股均价约84.83港元
荣昌生物(09995)进一步购买6000万元的华泰证券理财产品
智通财经 · 05-26 16:36
荣昌生物(09995)进一步购买6000万元的华泰证券理财产品
荣昌生物遭汇添富基金减持16万股 每股作价约84.83港元
新浪港股 · 05-24
荣昌生物遭汇添富基金减持16万股 每股作价约84.83港元
每周股票复盘：荣昌生物（688331）变更募投项目并调整注册资本
证券之星 · 05-24
每周股票复盘：荣昌生物（688331）变更募投项目并调整注册资本
汇添富基金减持荣昌生物(09995)16万股 每股作价约84.83港元
智通财经 · 05-22
汇添富基金减持荣昌生物(09995)16万股 每股作价约84.83港元
荣昌生物董事长王威东：国内销售、海外授权双向赋能丨21健谈
21世纪经济报道 · 05-20
荣昌生物董事长王威东：国内销售、海外授权双向赋能丨21健谈
荣昌生物同意从华泰证券等机构购买1500万元理财产品
美股速递 · 05-19
荣昌生物同意从华泰证券等机构购买1500万元理财产品
荣昌生物(09995)进一步购买3500万元的华泰证券理财产品
智通财经 · 05-19
荣昌生物(09995)进一步购买3500万元的华泰证券理财产品
荣昌生物：变更部分募投项目并调整金额 新增RC148子项目
财中社 · 05-18
荣昌生物：变更部分募投项目并调整金额 新增RC148子项目
荣昌生物：开展董事会换届选举 公布候选人名单
财中社 · 05-18
荣昌生物：开展董事会换届选举 公布候选人名单
荣昌生物：5月11日召开业绩说明会，《十五五·科创惠民--科创板企业成果转化与民生赋能之2025年度制药行业集体业绩说明》、《"对话成长"2025年度暨2026年一季度集体业绩说明会》参与
证券之星 · 05-15
荣昌生物：5月11日召开业绩说明会，《十五五·科创惠民--科创板企业成果转化与民生赋能之2025年度制药行业集体业绩说明》、《"对话成长"2025年度暨2026年一季度集体业绩说明会》参与
荣昌生物（688331）披露使用7000万美元闲置自有资金购买结构性存款产品公告，5月15日股价下跌0.98%
中金财经 · 05-15
荣昌生物（688331）披露使用7000万美元闲置自有资金购买结构性存款产品公告，5月15日股价下跌0.98%
荣昌生物(09995)购买理财产品
智通财经 · 05-15
荣昌生物(09995)购买理财产品
荣昌生物于5月6日同意从浦发银行烟台分行等机构购买总计8000万元理财产品
美股速递 · 05-13
荣昌生物于5月6日同意从浦发银行烟台分行等机构购买总计8000万元理财产品
荣昌生物(09995)近期合共购买14.3亿元的银行理财产品
智通财经 · 05-13
荣昌生物(09995)近期合共购买14.3亿元的银行理财产品
每周股票复盘：荣昌生物（688331）将召开2025年度暨2026年一季度业绩说明会
证券之星 · 05-10
每周股票复盘：荣昌生物（688331）将召开2025年度暨2026年一季度业绩说明会
荣昌生物（688331）披露参加‘对话成长’2025年度暨2026年一季度集体业绩说明会公告，5月6日股价下跌1.25%
证券之星 · 05-06
荣昌生物（688331）披露参加‘对话成长’2025年度暨2026年一季度集体业绩说明会公告，5月6日股价下跌1.25%
每周股票复盘：荣昌生物（688331）Q1净利增229.06%
证券之星 · 05-02
每周股票复盘：荣昌生物（688331）Q1净利增229.06%
荣昌生物（688331）2026年一季报简析：营收净利润同比双双增长
证券之星 · 04-30
荣昌生物（688331）2026年一季报简析：营收净利润同比双双增长
荣昌生物：第一季度净利润为3.28亿元，同比扭亏为盈
老虎资讯综合 · 04-28
荣昌生物：第一季度净利润为3.28亿元，同比扭亏为盈
加载更多
公司概况
公司名称：
荣昌生物制药(烟台)股份有限公司
所属行业：
医药制造业
上市日期：
2022-03-31
主营业务：
荣昌生物制药(烟台)股份有限公司的主营业务是研发、生产和销售医药产品、诊断试剂产品。公司的主要产品是泰它西普、维迪西妥单抗、RC28、RC148、RC278、RC288。
发行价格：
48.00
{"stockData":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":108.95,"timestamp":1779951601000,"preClose":112.69,"halted":0,"volume":8434979,"delay":0,"changeRate":-0.0332,"floatShares":163000000,"shares":564000000,"eps":2.2885,"marketStatus":"已收盘","change":-3.74,"latestTime":"05-28 15:00:01","open":113.5,"high":115.55,"low":108.3,"amount":932000000,"amplitude":0.0643,"askPrice":108.95,"askSize":116,"bidPrice":108.94,"bidSize":3,"shortable":0,"etf":0,"ttmEps":2.2885,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780018200000},"marketStatusCode":5,"adr":0,"adjPreClose":112.69,"symbolType":"stock_kcb","openAndCloseTimeList":[[1779931800000,1779939000000],[1779944400000,1779951600000]],"highLimit":123.96,"lowLimit":101.42,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":564477483,"isCdr":false,"pbRate":15.65,"roa":"--","peRate":47.607603,"roe":"8.68%","epsLYR":1.29,"committee":-0.792453,"marketValue":61500000000,"turnoverRate":0.0517,"status":1,"afterMarket":{"amount":76265,"volume":700,"close":108.95,"buyVolume":0,"sellVolume":0,"time":1779953637558,"indexStatus":"已收盘 05-28 15:30:00","preClose":112.69},"hkstockBrief":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":78.95,"timestamp":1779955711011,"preClose":82.3,"halted":0,"volume":3357426,"delay":0,"premium":"-37.35"},"floatMarketCap":17769000000},"requestUrl":"/m/hq/s/688331","defaultTab":"news","newsList":[{"id":"2638197575","title":"东方证券减持荣昌生物(09995)16万股 每股均价约84.83港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2638197575","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638197575?lang=zh_cn&edition=full","pubTime":"2026-05-26 19:30","pubTimestamp":1779795004,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月19日，东方证券减持荣昌生物(09995)16万股，每股均价84.8306港元，总金额约为1357.29万港元。减持后最新持股数目为1037.45万股，最新持股比例为4.97%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2148510915.USD","BK1161","09995","BK0012","BK1574","LU1064131003.USD","BK0028","LU2328871848.SGD","LU2488822045.USD","BK0188","BK0183","LU1064130708.USD","BK1583","BK0239","688331","LU1969619763.USD","BK1147","EWH","BK0276","BK1564","03958","600958"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638926345","title":"荣昌生物(09995)进一步购买6000万元的华泰证券理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2638926345","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638926345?lang=zh_cn&edition=full","pubTime":"2026-05-26 16:36","pubTimestamp":1779784596,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物(09995)发布公告，于2026年5月26日，本公司进一步与华泰证券订立华泰证券理财产品9号协议，据此本公司同意以人民币6000万元的闲置自有资金向华泰证券购买理财产品。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601688","LU0164865239.USD","LU1934453819.USD","LU2328871848.SGD","LU1781817850.SGD","LU0871576103.HKD","LU0531971595.HKD","LU1808992512.USD","LU2148510915.USD","688331","LU1580142542.USD","LU1064130708.USD","09995","BK0276","BK1161","BK0028","LU1979443071.USD","BK0183","BK0188","BK1574","BK0012","LU0039217434.USD","LU1328615791.USD","LU2488822045.USD","BK0239","BK1583","LU1064131003.USD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637086893","title":"荣昌生物遭汇添富基金减持16万股 每股作价约84.83港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637086893","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637086893?lang=zh_cn&edition=full","pubTime":"2026-05-24 16:30","pubTimestamp":1779611400,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 香港联交所最新资料显示，5月19日，汇添富基金减持荣昌生物（09995）16万股，每股作价84.8306港元，总金额约为1357.29万港元。减持后最新持股数目为1037.45万股，最新持股比例为4.97%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-05-24/doc-inhyytnn4398818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688331","LU2328871848.SGD","BK1161","LU1064130708.USD","BK1574","LU2488822045.USD","LU1969619763.USD","09995","LU1064131003.USD","LU2148510915.USD","EWH","BK1583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637378691","title":"每周股票复盘：荣昌生物（688331）变更募投项目并调整注册资本","url":"https://stock-news.laohu8.com/highlight/detail?id=2637378691","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637378691?lang=zh_cn&edition=full","pubTime":"2026-05-24 01:17","pubTimestamp":1779556631,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，荣昌生物报收于116.7元，较上周的114.66元上涨1.78%。公司公告汇总荣昌生物第二届董事会第三十八次会议审议通过多项议案，包括部分募投项目子项目变更及金额调整、董事会换届选举非独立董事和独立董事候选人、变更注册资本并修订公司章程、修订及制定部分内部管理制度，并提请召开2025年年度股东会。荣昌生物拟对A股首次公开发行募集资金投资项目中的“抗肿瘤抗体新药研发项目”部分临床试验子项目进行调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK0239","09995","BK1583","LU1064130708.USD","LU2328871848.SGD","LU1064131003.USD","LU2148510915.USD","BK1574","688331","LU1969619763.USD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637831217","title":"汇添富基金减持荣昌生物(09995)16万股 每股作价约84.83港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2637831217","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637831217?lang=zh_cn&edition=full","pubTime":"2026-05-22 20:49","pubTimestamp":1779454173,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月19日，汇添富基金减持荣昌生物(09995)16万股，每股作价84.8306港元，总金额约为1357.29万港元。减持后最新持股数目为1037.45万股，最新持股比例为4.97%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1445275.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1969619763.USD","688331","09995","BK1583","BK0239","LU2328871848.SGD","LU2148510915.USD","EWH","BK1574","LU1064131003.USD","LU1064130708.USD","BK1161","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636881660","title":"荣昌生物董事长王威东：国内销售、海外授权双向赋能丨21健谈","url":"https://stock-news.laohu8.com/highlight/detail?id=2636881660","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636881660?lang=zh_cn&edition=full","pubTime":"2026-05-20 14:46","pubTimestamp":1779259586,"startTime":"0","endTime":"0","summary":"2026年一季度创新药企业绩成绩单出炉，荣昌生物（688331.SH/9995.HK）经营成效显著。数据显示，报告期内荣昌生物营收6.56亿元，同比增长24.76%，归母净利润3.28亿元，较上年同期成功扭亏为盈。对于创业十八年的老牌企业荣昌生物而言，盈利意味着战略姿态的主动化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605203743371973.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605203743371973.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","LU2328871848.SGD","LU2488822045.USD","BK1574","BK1583","LU1064131003.USD","LU2148510915.USD","688331","LU1969619763.USD","LU1064130708.USD","09995","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125330267","title":"荣昌生物同意从华泰证券等机构购买1500万元理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1125330267","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125330267?lang=zh_cn&edition=full","pubTime":"2026-05-19 19:21","pubTimestamp":1779189674,"startTime":"0","endTime":"0","summary":"荣昌生物宣布，已达成协议，将从华泰证券及其他相关方购入价值总计1500万元人民币的理财产品。此项财务安排旨在优化公司闲置资金管理，提升资金使用效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","LU2148510915.USD","LU2488822045.USD","LU1064131003.USD","688331","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636853600","title":"荣昌生物(09995)进一步购买3500万元的华泰证券理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2636853600","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636853600?lang=zh_cn&edition=full","pubTime":"2026-05-19 19:20","pubTimestamp":1779189643,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物(09995)公布，于2026年5月19日，公司进一步与华泰证券订立(1)华泰证券理财产品5号协议，据此公司同意以人民币1500万元的闲置自有资金向华泰证券购买理财产品;及(2)华泰证券理财产品6号协议，据此公司同意以人民币2000万元的闲置自有资金向华泰证券购买理财产品。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1443564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0012","LU1979443071.USD","LU0039217434.USD","BK0239","09995","BK0183","LU1328615791.USD","BK1583","BK0188","BK0028","BK1161","LU1934453819.USD","BK0276","LU1969619763.USD","LU1808992512.USD","BK1574","LU2328871848.SGD","LU2488822045.USD","LU1064131003.USD","601688","LU1064130708.USD","LU0531971595.HKD","LU0871576103.HKD","LU0164865239.USD","LU1781817850.SGD","688331","LU2148510915.USD","LU1580142542.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636073722","title":"荣昌生物：变更部分募投项目并调整金额 新增RC148子项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2636073722","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636073722?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:07","pubTimestamp":1779106020,"startTime":"0","endTime":"0","summary":"5月18日，荣昌生物（688331/09995）发布公告，为提高募集资金使用效率，公司决定对“抗肿瘤抗体新药研发项目”中的部分临床试验子项目进行调整。本次变更的主要内容包括新增子项目RC148，并将RC88、RC108及RC118子项目的剩余募集资金调减，募集资金投资总金额保持不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740712037.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","09995","LU2148510915.USD","LU2488822045.USD","BK1583","LU1064131003.USD","LU2328871848.SGD","LU1969619763.USD","BK1161","LU1064130708.USD","688331","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636073703","title":"荣昌生物：开展董事会换届选举 公布候选人名单","url":"https://stock-news.laohu8.com/highlight/detail?id=2636073703","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636073703?lang=zh_cn&edition=full","pubTime":"2026-05-18 20:07","pubTimestamp":1779106020,"startTime":"0","endTime":"0","summary":"荣昌生物（688331/09995）发布公告，根据相关法律法规，公司于2026年5月18日召开第二届董事会第三十八次会议，审议通过了关于董事会换届选举的议案。经公司董事会提名委员会对第三届董事会董事候选人任职资格的审查，提名王威东、房健民、温庆凯、王荔强、房艺为非独立董事候选人，提名宋希亮、黄国滨、陈云金为独立董事候选人。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605183740711871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2148510915.USD","BK1161","LU2328871848.SGD","BK1574","688331","BK0239","LU1064130708.USD","BK1583","LU1064131003.USD","LU2488822045.USD","09995","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635088673","title":"荣昌生物：5月11日召开业绩说明会，《十五五·科创惠民--科创板企业成果转化与民生赋能之2025年度制药行业集体业绩说明》、《\"对话成长\"2025年度暨2026年一季度集体业绩说明会》参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2635088673","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635088673?lang=zh_cn&edition=full","pubTime":"2026-05-15 18:03","pubTimestamp":1778839422,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年5月15日荣昌生物发布公告称公司于2026年5月11日召开业绩说明会，《十五五·科创惠民--科创板企业成果转化与民生赋能之2025年度制药行业集体业绩说明》、《\"对话成长\"2025年度暨2026年一季度集体业绩说明会》参与。泰它西普治疗重症肌无力适应症已于2025年12月成功纳入国家医保目录，目前按医保支付标准执行。公司目前生产经营活动正常，不存在应披露而未披露的重大","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500034801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1583","09995","LU2328871848.SGD","BK1191","LU1969619763.USD","159982","LU2488822045.USD","LU1064130708.USD","01477","LU1064131003.USD","LU2148510915.USD","688331","BK0239","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635088379","title":"荣昌生物（688331）披露使用7000万美元闲置自有资金购买结构性存款产品公告，5月15日股价下跌0.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635088379","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635088379?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:54","pubTimestamp":1778838887,"startTime":"0","endTime":"0","summary":"近日，荣昌生物制药(烟台)股份有限公司与华侨银行订立理财产品协议，使用美元70.0百万元的闲置自有资金购买收益联结型结构性存款产品，产品起始日为2026年5月21日，到期日为2027年5月19日，预期年化收益率随市场波动。该交易构成联交所上市规则下的须予披露交易，已获董事会批准，交易条款公平合理，符合公司及股东整体利益。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260515/32228130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU2148510915.USD","LU2328871848.SGD","BK1161","LU2488822045.USD","09995","BK1574","BK1583","LU1064131003.USD","BK0239","688331","LU1969619763.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635722376","title":"荣昌生物(09995)购买理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2635722376","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635722376?lang=zh_cn&edition=full","pubTime":"2026-05-15 07:04","pubTimestamp":1778799869,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物(09995)发布公告，2026年5月14日，公司与华泰证券订立(1)华泰证券理财产品1号协议，据此公司同意以人民币6000万元的闲置自有资金向华泰证券购买理财产品;(2)华泰证券理财产品2号协议，据此公司同意以人民币7500万元的闲置自有资金向华泰证券购买理财产品;(3)华泰证券理财产品3号协议，据此本公司同意以人民币1.02亿元的闲置自有资金向华泰证券购买理财产品及(4)华泰证券理财产品4号协议，据此公司同意以人民币2.16亿元的闲置自有资金向华泰证券购买理财产品。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441979.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2148510915.USD","BK1161","LU2328871848.SGD","BK1574","688331","BK0239","LU1064130708.USD","BK1583","LU1064131003.USD","LU2488822045.USD","09995","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130772072","title":"荣昌生物于5月6日同意从浦发银行烟台分行等机构购买总计8000万元理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1130772072","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130772072?lang=zh_cn&edition=full","pubTime":"2026-05-13 19:02","pubTimestamp":1778670170,"startTime":"0","endTime":"0","summary":"荣昌生物于5月6日与上海浦东发展银行股份有限公司烟台分行及其他相关方达成协议，购买总额为人民币8000万元的理财产品。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688331","LU1064131003.USD","LU2488822045.USD","LU2148510915.USD","LU1064130708.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635866917","title":"荣昌生物(09995)近期合共购买14.3亿元的银行理财产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2635866917","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635866917?lang=zh_cn&edition=full","pubTime":"2026-05-13 18:57","pubTimestamp":1778669853,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物 公布，于2026年4月28日，公司与浦发银行烟台分行订立浦发银行理财产品1号协议及浦发银行理财产品2号协议，据此公司同意分别以人民币2.2亿元及8000万元的闲置自有资金向浦发银行烟台分行购买理财产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441308.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2148510915.USD","LU2328871848.SGD","BK1161","LU2488822045.USD","09995","BK1574","BK1583","LU1064131003.USD","BK0239","688331","LU1969619763.USD","LU1064130708.USD","161121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634411573","title":"每周股票复盘：荣昌生物（688331）将召开2025年度暨2026年一季度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2634411573","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634411573?lang=zh_cn&edition=full","pubTime":"2026-05-10 01:24","pubTimestamp":1778347450,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，荣昌生物报收于123.9元，较上周的129.31元下跌4.18%。本周，荣昌生物5月8日盘中最高价报132.02元。本周关注点公司公告汇总：荣昌生物将于2026年5月14日召开2025年度暨2026年一季度集体业绩说明会。公司公告汇总荣昌生物制药（烟台）股份有限公司将于2026年5月14日下午15:00-16:15通过上证路演中心和第一财经平台，以视频和线上文字互动方式召开2025年度暨2026年一季度集体业绩说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000227.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1064131003.USD","LU1064130708.USD","BK1574","688331","BK1583","LU1969619763.USD","BK1161","LU2488822045.USD","LU2148510915.USD","09995","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633315551","title":"荣昌生物（688331）披露参加‘对话成长’2025年度暨2026年一季度集体业绩说明会公告，5月6日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633315551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633315551?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:05","pubTimestamp":1778076320,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，荣昌生物报收于127.7元，较前一交易日下跌1.25%，最新总市值为720.84亿元。该股当日开盘129.0元，最高130.32元，最低127.5元，成交额达13.71亿元，换手率为6.52%。荣昌生物制药（烟台）股份有限公司近日披露《关于参加“对话成长”2025年度暨2026年一季度集体业绩说明会的公告》。公告显示，公司将于2026年5月14日下午15:00-16:15通过上证路演中心和第一财经平台，以视频和线上文字互动方式召开2025年度暨2026年一季度集体业绩说明会。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600039554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","688331","LU2488822045.USD","BK1161","BK1574","LU1064130708.USD","LU2328871848.SGD","BK0239","LU1969619763.USD","BK1583","LU1064131003.USD","LU2148510915.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632493046","title":"每周股票复盘：荣昌生物（688331）Q1净利增229.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632493046","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632493046?lang=zh_cn&edition=full","pubTime":"2026-05-02 01:26","pubTimestamp":1777656371,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，荣昌生物报收于129.31元，较上周的133.03元下跌2.8%。本周，荣昌生物4月28日盘中最高价报139.98元。股本股东变化截至2026年3月31日，荣昌生物股东户数为1.97万户，较2月28日增加2264户，增幅达12.97%。业绩披露要点荣昌生物2026年一季报显示，主营收入6.56亿元，同比增长24.76%；归母净利润3.28亿元，同比上升229.06%；扣非净利润-3499.1万元，同比改善86.12%；负债率为46.66%，毛利率为82.18%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1161","09995","LU2328871848.SGD","LU2488822045.USD","BK1583","LU1064130708.USD","LU1969619763.USD","BK1574","LU2148510915.USD","LU1064131003.USD","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631578474","title":"荣昌生物（688331）2026年一季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2631578474","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631578474?lang=zh_cn&edition=full","pubTime":"2026-04-30 06:54","pubTimestamp":1777503282,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期荣昌生物发布2026年一季报。根据财报显示，荣昌生物营收净利润同比双双增长。截至本报告期末，公司营业总收入6.56亿元，同比上升24.76%，归母净利润3.28亿元，同比上升229.06%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000023900.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137868631","title":"荣昌生物：第一季度净利润为3.28亿元，同比扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=1137868631","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137868631?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:48","pubTimestamp":1777366101,"startTime":"0","endTime":"0","summary":"4月28日，$荣昌生物(09995)$公告称，2026年第一季度实现营业收入6.56亿元，同比增长24.76%；归属于上市公司股东的净利润为3.28亿元，同比扭亏为盈。业绩变动主要系商业化产品销售收入持续增加，以及产品技术授权导致研发投入减少，认股权证公允价值变动所致。小财注：公司Q1净利润3.28亿，2025年Q4净利润12.6亿，据此计算，Q1净利润环比下降73%。","market":"sh","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"324431b18d184842b2237adf08e51534","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荣昌生物：第一季度净利润为3.28亿元，同比扭亏为盈","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1574","688331","09995","LU2148510915.USD","LU1969619763.USD","BK0239","LU1064131003.USD","LU2328871848.SGD","LU2488822045.USD","LU1064130708.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1779996408849,"stockEarnings":[{"period":"1week","weight":-0.1069},{"period":"1month","weight":-0.1906},{"period":"3month","weight":0.1042},{"period":"6month","weight":0.0928},{"period":"1year","weight":0.9307},{"period":"ytd","weight":0.4006}],"compareEarnings":[{"period":"1week","weight":0.0052},{"period":"1month","weight":0.0049},{"period":"3month","weight":-0.0154},{"period":"6month","weight":0.054},{"period":"1year","weight":0.2272},{"period":"ytd","weight":0.0327}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"荣昌生物制药(烟台)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"19720人(较上一季度增加12.97%)","perCapita":"8270股","listingDate":"2022-03-31","address":"山东省烟台市福山区中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号","registeredCapital":"56447万元","survey":" 荣昌生物制药(烟台)股份有限公司的主营业务是研发、生产和销售医药产品、诊断试剂产品。公司的主要产品是泰它西普、维迪西妥单抗、RC28、RC148、RC278、RC288。","listedPrice":48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(688331)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(688331)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,688331,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(688331)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(688331)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}